Entries for December 2017
posted on December 21, 2017
In 2011, the Food & Drug Administration ordered post-market safety trials to be conducted on combination long-acting beta agonist (LABA) and inhaled corticosteroid (ICS) inhalers. This review was prompted by the discovery that using LABA inhaler...
posted on December 20, 2017
The U.S. Food & Drug Administration (FDA) has approved the long-acting muscarinic antagonist (LAMA) glycopyrrolate in nebulizer form for treatment of COPD. This is the first time a LAMA medication will be available via nebulizer. According to ...